Kirr Marbach & Co. LLC IN Lowers Stock Position in Innospec Inc. (NASDAQ:IOSP)

Kirr Marbach & Co. LLC IN lowered its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,696 shares of the specialty chemicals company’s stock after selling 747 shares during the period. Innospec accounts for 1.9% of Kirr Marbach & Co. LLC IN’s investment portfolio, making the stock its 19th largest holding. Kirr Marbach & Co. LLC IN owned 0.31% of Innospec worth $8,551,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. HighTower Advisors LLC grew its stake in shares of Innospec by 5.2% during the 3rd quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company’s stock worth $350,000 after purchasing an additional 154 shares during the period. Raymond James Trust N.A. boosted its holdings in Innospec by 7.9% during the third quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company’s stock worth $238,000 after buying an additional 155 shares in the last quarter. Creative Planning grew its position in Innospec by 4.3% during the second quarter. Creative Planning now owns 4,762 shares of the specialty chemicals company’s stock worth $589,000 after buying an additional 195 shares during the period. Thrivent Financial for Lutherans increased its holdings in Innospec by 0.3% in the third quarter. Thrivent Financial for Lutherans now owns 59,602 shares of the specialty chemicals company’s stock valued at $6,740,000 after buying an additional 195 shares in the last quarter. Finally, Stonegate Investment Group LLC lifted its position in shares of Innospec by 10.9% during the 3rd quarter. Stonegate Investment Group LLC now owns 2,208 shares of the specialty chemicals company’s stock valued at $250,000 after acquiring an additional 217 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors.

Innospec Stock Up 0.2 %

Shares of IOSP stock opened at $114.96 on Wednesday. Innospec Inc. has a fifty-two week low of $103.65 and a fifty-two week high of $133.71. The business has a fifty day simple moving average of $113.57 and a 200-day simple moving average of $114.40. The stock has a market cap of $2.87 billion, a P/E ratio of 20.06 and a beta of 1.09.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The company had revenue of $443.40 million for the quarter, compared to the consensus estimate of $442.13 million. During the same quarter in the prior year, the firm earned $1.59 earnings per share. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Innospec Inc. will post 5.88 earnings per share for the current year.

Innospec Increases Dividend

The business also recently declared a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were given a dividend of $0.79 per share. This is an increase from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend was Monday, November 18th. This represents a yield of 1.3%. Innospec’s dividend payout ratio (DPR) is presently 27.57%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 11th.

Insider Transactions at Innospec

In other news, Director Milton C. Blackmore sold 1,035 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total value of $127,222.20. Following the completion of the transaction, the director now owns 9,028 shares of the company’s stock, valued at $1,109,721.76. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.52% of the company’s stock.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.